Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Curis (United States) | Researchclopedia

Back to institutions

Curis (United States)

Lexington, Massachusettscompany

194

Works

48,484

Citations

129

h-index

Top Research Topics

Histone Deacetylase Inhibitors Research Hedgehog Signaling Pathway Studies Protein Degradation and Inhibitors

Top Researchers

Frédéric J. de Sauvage Genentech

301 works48,689 citationsh-index: 103

Recent Research

EXTH-119. Targeting myddosome signaling to improve immunotherapy in melanoma brain metastases

Christina A. Von Roemeling,Bently P. Doonan,et al.

20250 citations

Lymphoma Diagnosis and Treatment

Cancer Immunotherapy and Biomarkers

Acute Myeloid Leukemia Research

Chronic Lymphocytic Leukemia Research

CAR-T cell therapy research

Epigenetics and DNA Methylation

Neurogenesis and neuroplasticity mechanisms

CNS Lymphoma Diagnosis and Treatment

Ubiquitin and proteasome pathways

Zora Modrušan Genomic Health (United States)

590 works43,739 citationsh-index: 102

Jing Wang Xiamen University of Technology

973 works35,103 citationsh-index: 74

Jing Wang National Institute of Biological Sciences, Beijing

1,198 works34,404 citationsh-index: 85

Jing Wang Linköping University

1,833 works30,279 citationsh-index: 72

Lee L. Rubin Broad Institute

247 works26,210 citationsh-index: 77

CTNI-59. ANALYSIS OF GENETIC MUTATION PROFILE AND CNS PHARMACOKINETICS IN RELAPSED/REFRACTORY PRIMARY CNS LYMPHOMA PATIENTS RESPONDING TO NOVEL EMAVUSERTIB (IRAK4I) AND BTKI COMBINATION

Christian Grommes,Anna Dąbrowska‐Iwanicka,et al.

20250 citations

CTNI-63. PRELIMINARY SAFETY AND EFFICACY OF EMAVUSERTIB (CA-4948) IN COMBINATION WITH IBRUTINIB IN RELAPSED/REFRACTORY PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA PATIENTS

Lakshmi Nayak,Anna Dąbrowska‐Iwanicka,et al.

20250 citations

Analysis of genetic mutation profile and CNS pharmacokinetics in relapsed/refractory primary CNS lymphoma patients responding to novel emavusertib (IRAK4i) and BTKi combination.

Christian Grommes,Anna Dąbrowska‐Iwanicka,et al.

20250 citations

The role of artificial intelligence in pharmacovigilance for rare diseases

Ashish S. Jain,Zahabia Adenwala

20252 citations

Ovarian Stimulation Effects on Ghrelin Secretion and Reproductive Potential

Fernando Beltramone,Patricia Estofán,et al.

20240 citations